Hutchison China MediTech Ltd ("Chi-Med"): Focused on discovering, developing and commercializing targeted therapeutics and immunotherapies in oncology and autoimmune diseases. Chi-Med has a portfolio of 8 drugs in clinical development from own discovery engine in its Innovation platform and a cash generating Commercial platform with 2,500+ sales reps. Launched fruquintinib, partnered with Eil Lilly, in late stage colorectal cancer in China in November 2018. Global collaboration with AstraZeneca in two registration enabling studies with savolitinib in Tagrisso refractory lung cancer that is MET+ and EGFRm+ (global) and MET Exon 14 deletion NSCLC (China). Potential to start two registration programs globally in 2020.
Sector/industry:
Healthcare/Biotechnology
Characteristics:
Based in...
Asia, US - Middle Atlantic
Clinical Stage
Marketed, Phase III, Phase l or ll
Disease Space
Anti-inflammatory, Autoimmune, Immunotherapy, Oncology
Finance
Profitable, Revenues
Industry
Biotechnology
Listing
Public, USA
Market Cap
1B +
Website:
Address:
230 Park Ave
10th Fl
New York, NY 10169
United States

Company Participants at Hamptons CEO Roundtable 2019

  • Annie Cheng

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Top 10 Holders of Hutchison China Meditech Ltd Sponsored ADR

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Capital International, Inc. 3.64 4,855,544 136.20 13F 2020-03-31
M&G Investment Management Ltd. 2.93 3,900,189 109.40 13F 2020-03-31
Invesco Advisers, Inc. 2.60 3,460,461 97.07 13F 2020-03-31
Capital Research & Management Co. (International Investors) 2.28 3,045,080 85.41 13F 2020-03-31
Sands Capital Management LLC 1.78 2,371,925 66.53 13F 2020-03-31
Capital Research & Management Co. (World Investors) 1.70 2,271,707 63.72 Funds 2020-03-31
Schroder Investment Management (Singapore) Ltd. 1.57 2,091,335 58.66 13F 2020-03-31
Wellington Management Co. LLP 1.38 1,837,429 51.54 13F 2020-03-31
Schroder Investment Management (Hong Kong) Ltd. 1.21 1,614,629 45.29 13F 2020-03-31
BlackRock Fund Advisors 1.15 1,534,850 43.05 13F 2020-03-31
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.